Holen Sie sich die Stockscreener-App
108.12
0.00%
-0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Abbott Laboratories Stock (ISIN: US0028241000) Faces Pressure Amid Diagnostics Slowdown and Obesity - AD HOC NEWS
Benchmark reiterates Abbott stock rating on diabetes trial results - Investing.com
Abbott Launches ICRAS Tool to Assess Heart and Kidney Risks in Diabetes Patients - The Indian Practitioner
Intravenous (IV) Solutions Market Size to Reach USD 29.47 Billion by 2035 Due to the Increasing Prevalence of Chronic Diseases Globally | SNS Insider - GlobeNewswire Inc.
How The Story On Abbott Laboratories (ABT) Is Shifting As Analysts Rework Targets And Risks - Yahoo Finance
Abbott study highlights better glucose outcomes with Libre CGM in type 2 diabetes on basal insulin - MassDevice
Abbott (ABT) Showcases Positive Outcomes with FreeStyle Libre in Diabetes Management - GuruFocus
Abbott Laboratories $ABT Holdings Trimmed by Elevatus Welath Management - MarketBeat
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & SuppliesDiversified Stocks - Yahoo Finance
Abbott’s Freedom To Work Plan And What It May Mean For NYSE ABT - simplywall.st
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management - Bolsamania
Diverging Views Emerge on Abbott Laboratories' Stock Outlook - AD HOC NEWS
Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' - Investing News Network
Citigroup Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat
Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' – Company Announcement - Financial Times
Intuitive Surgical Upgraded to Buy by Citi — Plus Key Moves on Stryker and Abbott - 24/7 Wall St.
Van ECK Associates Corp Has $50.42 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Mackenzie Financial Corp Buys 29,440 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Bought by Franklin Resources Inc. - MarketBeat
Vitamin D Testing Market Is Going to Boom |• Abbott • Roche Diagnostics • Siemens Healthineers - openPR.com
Capital World Investors Grows Holdings in Abbott Laboratories $ABT - MarketBeat
Opening arguments begin in first Illinois trial against Abbott over its formula for premature babies - The Daily Gazette
Is Abbott Laboratories (ABT) Pricing Reflect Its Mixed Share Performance And Growth Prospects? - Yahoo Finance
MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed™ 780G system with the Instinct sensor, made by Abbott - BioSpace
Capital International Sarl Buys 12,412 Shares of Abbott Laboratories $ABT - MarketBeat
Is It Time To Revisit Abbott Laboratories (ABT) After Recent Share Price Weakness? - simplywall.st
Abbott Laboratories (ABT) Announces $20 Billion Senior Notes Off - GuruFocus
Abbott Formula Linked To 'Horrible' Gut Disease, Ill. Jury Told - Law360
Abbott Laboratories Completes Major Senior Notes Offering - TipRanks
Four-Plaintiff Chicago Trial Opens Against Abbott Over Preterm Infant Formula - Law.com
Abbott Laboratories Offers Long-Term Upside Despite Recent Stumbles (NYSE:ABT) - Seeking Alpha
Vinva Investment Management Ltd Has $10.21 Million Stake in Abbott Laboratories $ABT - MarketBeat
Russell Investments Group Ltd. Purchases 92,788 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Bought by Dundas Partners LLP - MarketBeat
Abbott Laboratories Pakistan : Board Meeting - marketscreener.com
B. Metzler seel. Sohn & Co. AG Raises Stock Position in Abbott Laboratories $ABT - MarketBeat
First Trust Advisors LP Buys 810,684 Shares of Abbott Laboratories $ABT - MarketBeat
NEC Baby Formula Lawsuit & Settlement | March 2026 Update - Lawsuit Information Center
A Look At Abbott Laboratories (ABT) Valuation After Recent Share Price Volatility - simplywall.st
Abbott IP chief: ‘Firms without AI policies scare me’ - Life Sciences Intellectual Property Review
Abbott Laboratories $ABT Shares Sold by Victory Capital Management Inc. - MarketBeat
Abbott Laboratories $ABT Shares Sold by Orion Porfolio Solutions LLC - MarketBeat
Abbott Faces Trial Over Claims Its Infant Formula Caused Bowel Disease in Premature Babies - The Indian Practitioner
Trial over Abbott Laboratories’ formula for premature babies set to begin this week - Times West Virginian
Crossmark Global Holdings Inc. Purchases 12,373 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Labs to face trial on infant formula - The Economic Times
Trial over Abbott Laboratories’ formula for premature babies set to begin in Chicago this week - The Daily Gazette
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Daywatch: Trial over Abbott Laboratories’ formula for premature babies set to begin - Chicago Tribune
Abbott set to face trial over claims premature infant formula caused deadly disease - Reuters
Trial over Abbott Laboratories’ formula for premature babies set to begin in Cook County this week - Chicago Tribune
Dimensional Fund Advisors LP Purchases 169,115 Shares of Abbott Laboratories $ABT - MarketBeat
US002824BU37 Bond Price and Chart — SWB:US002824BU37 - TradingView
Abbott Laboratories EVP Cushman sells $30k in stock - Investing.com Australia
A4EQ5K Bond Price and Chart — GETTEX:A4EQ5K - TradingView
Abbott Laboratories EVP Cushman sells $30k in stock By Investing.com - Investing.com UK
Insider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 613 Shares of Stock - MarketBeat
Abbott Laboratories (NYSE:ABT) EVP Sells $102,288.30 in Stock - MarketBeat
Insider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 263 Shares of Stock - MarketBeat
Insider Sell: Elizabeth Cushman Sells Shares of Abbott Laborator - GuruFocus
Abbott (ABT) SVP Eric Shroff logs share sale and tax disposition - Stock Titan
Abbott Laboratories (ABT) EVP logs 4,997-share tax-withholding disposition on Form 4 - Stock Titan
Abbott (NYSE: ABT) EVP logs share sale and tax disposition - Stock Titan
0.98%
2.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):